These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 5315660)
1. Elevation of thymidylate synthetase activity in CCRF-CEM cells. Roberts D; Loehr EV Cancer Res; 1971 Sep; 31(9):1181-7. PubMed ID: 5315660 [No Abstract] [Full Text] [Related]
2. Methotrexate and cytosine arabinoside modulation of thymidylate synthetase activity in CCRF-CEM cells. Roberts D; Loehr EV Cancer Res; 1971 Apr; 31(4):457-62. PubMed ID: 5553690 [No Abstract] [Full Text] [Related]
3. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines. Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate inhibition of CCRF-CEM cultures of human lymphoblasts. Roberts D; Warmath EV Eur J Cancer (1965); 1975 Nov; 11(11):771-82. PubMed ID: 130240 [No Abstract] [Full Text] [Related]
5. Depression of thymidylate synthetase activity in response to cytosine arabinoside. Roberts D; Loehr EV Cancer Res; 1972 Jun; 32(6):1160-9. PubMed ID: 4503638 [No Abstract] [Full Text] [Related]
6. 5-Nitro-2'-deoxyuridine and 5-nitro-2'-deoxyuridine 5'-monophosphate: antiviral activity and inhibition of thymidylate synthetase in vivo. De Clercq E; Descamps J; Huang GF; Torrence PF Mol Pharmacol; 1978 May; 14(3):422-30. PubMed ID: 661811 [No Abstract] [Full Text] [Related]
7. Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells. Washtien WL Mol Pharmacol; 1982 May; 21(3):723-8. PubMed ID: 6213845 [TBL] [Abstract][Full Text] [Related]
8. Deoxyuridine metabolism in cultured human lymphoblasts treated with methotrexate. Perez DJ; Slowiaczek P; Tattersall MH Cancer Res; 1984 Feb; 44(2):457-60. PubMed ID: 6198074 [TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth. De Clercq E; Balzarini J; Torrence PF; Mertes MP; Schmidt CL; Shugar D; Barr PJ; Jones AS; Verhelst G; Walker RT Mol Pharmacol; 1981 Mar; 19(2):321-30. PubMed ID: 7231392 [No Abstract] [Full Text] [Related]
10. Studies relating to the mode of action of methotrexate. 3. Inhibition of thymidylate synthetase in tissue culture cells and in cell-free systems. Borsa J; Whitmore GF Mol Pharmacol; 1969 Jul; 5(4):318-32. PubMed ID: 4896040 [No Abstract] [Full Text] [Related]
11. Mutants of Chinese hamster cells deficient in thymidylate synthetase. Li IC; Chu EH J Cell Physiol; 1984 Aug; 120(2):109-16. PubMed ID: 6611339 [TBL] [Abstract][Full Text] [Related]
12. Differential calcium leucovorin protection of human lymphoid cell lines from methotrexate. Browman GP; Booker L; Spiegl P Cancer Chemother Pharmacol; 1985; 15(2):105-10. PubMed ID: 2410158 [TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines. McGuire JJ; Magee KJ; Russell CA; Canestrari JM Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499 [TBL] [Abstract][Full Text] [Related]
14. Cytidine 5'-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine. McPartland RP; Wang MC; Bloch A; Weinfeld H Cancer Res; 1974 Nov; 34(11):3107-11. PubMed ID: 4472653 [No Abstract] [Full Text] [Related]
15. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists. Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176 [TBL] [Abstract][Full Text] [Related]
16. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase. Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766 [TBL] [Abstract][Full Text] [Related]
17. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone. Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry. Taylor IW; Tattersall MH Cancer Res; 1981 Apr; 41(4):1549-58. PubMed ID: 6163527 [TBL] [Abstract][Full Text] [Related]
19. Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization. McGuire JJ; Bergoltz VV; Heitzman KJ; Haile WH; Russell CA; Bolanowska WE; Kotake Y; Haneda T; Nomura H Cancer Res; 1994 May; 54(10):2673-9. PubMed ID: 8168096 [TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthetase of human lymphocytes augmented in vitro by methotrexate. Haurani FI; Herman GM; Abboud EM Cancer Biochem Biophys; 1985 Jun; 8(1):29-33. PubMed ID: 4027943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]